People on the Move
Medherant’s new Chair Ken Cunningham
Medherant Ltd. has elected Ken Cunningham to be the UK-based firm’s Chair.
Medherant is a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, preparing to move into clinical studies with its lead tech the TEPI Patch.
Ken is currently Chairman of UK-firms Abzena Plc as well as Non-Executive Director of Verona Pharma plc. Before Medharent, Cunningham was at SkyePharma plc, initially as COO and then CEO, where he oversaw the late stage development of flutiform for asthma.
